Successful treatment based on molecular biological assessment of invasive anaplastic lymphoma kinase-positive inflammatory myofibroblastic tumor of the lung

MLA

Hironosuke Watanabe, et al. “Successful Treatment Based on Molecular Biological Assessment of Invasive Anaplastic Lymphoma Kinase-Positive Inflammatory Myofibroblastic Tumor of the Lung.” Surgical Case Reports, vol. 5, no. 1, July 2019, pp. 1–4. EBSCOhost, https://doi.org/10.1186/s40792-019-0674-x.

APA

Hironosuke Watanabe, Naoya Yamasaki, Takuro Miyazaki, Keitaro Matsumoto, Tomoshi Tsuchiya, Kuniko Abe, & Takeshi Nagayasu. (2019). Successful treatment based on molecular biological assessment of invasive anaplastic lymphoma kinase-positive inflammatory myofibroblastic tumor of the lung. Surgical Case Reports, 5(1), 1–4. https://doi.org/10.1186/s40792-019-0674-x

Chicago

Hironosuke Watanabe, Naoya Yamasaki, Takuro Miyazaki, Keitaro Matsumoto, Tomoshi Tsuchiya, Kuniko Abe, and Takeshi Nagayasu. 2019. “Successful Treatment Based on Molecular Biological Assessment of Invasive Anaplastic Lymphoma Kinase-Positive Inflammatory Myofibroblastic Tumor of the Lung.” Surgical Case Reports 5 (1): 1–4. doi:10.1186/s40792-019-0674-x.